Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Up 96.4% in August

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 2,283,272 shares, a growth of 96.4% from the August 15th total of 1,162,372 shares. Based on an average daily volume of 565 shares, the short-interest ratio is currently 4,041.2 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

OTCMKTS:SFOSF opened at $2.20 on Wednesday. The firm has a 50-day simple moving average of $2.16 and a 200-day simple moving average of $2.31. Shanghai Fosun Pharmaceutical has a one year low of $1.93 and a one year high of $3.50.

Shanghai Fosun Pharmaceutical (Group) Company Profile

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.